Will Archer Daniels' Strategic Moves & Cost Savings Aid Growth?

Friday, Mar 20, 2026 3:13 pm ET2min read
ADM--
Aime RobotAime Summary

- ADMADM-- is optimizing operations, cutting costs, and expanding alternative protein capabilities to enhance efficiency and long-term value.

- The company is advancing digital initiatives and adapting to consumer trends in health and wellness, driving innovation and margin growth.

- ADM's shares gained 12% in six months, trading at a forward P/E of 16.86X, with projected 2026 EPS growth of 22.7%.

- Strategic simplification and improved performance in Human Nutrition and Flavors portfolios are boosting profitability and market confidence.

Archer Daniels Midland Company ADM is focused on optimizing the organizational and operational structure. The company is actively managing productivity and innovation as well as aligning work to the interconnected trends in food security, health and wellbeing. ADMADM-- has been strengthening its internal controls, enhancing execution, improving operational efficiency and reducing costs, while streamlining its portfolio to sharpen core competencies and unlock long-term value.

Archer Daniels is smoothly progressing on its key strategic pillars, including optimize, drive and growth. Under the optimize pillar, the company had expanded its alternative protein capabilities and starch production. It continues to adapt to consumers’ changing nutritional preferences. Under its drive pillar, the company is adapting its organizational structure to meet operational excellence. ADM is focused on expanding its footprint in fast-growing alternative protein.

ADM has also been creating additional margin opportunities, opening up channels to customers, advancing digital technologies in areas like farmer needs, and growing its BioSolutions platform. In addition, the company is advancing key innovation initiatives in areas like health & wellness, supporting improved customer demand. It is focused on strategic simplification.

In addition, Archer Daniels’ Nutrition segment is showing signs of recovery, led by improving performance in Human Nutrition. Management highlighted strength in the Flavors portfolio, supported by solid demand in North America and new international customer wins. Margin expansion in Flavors, driven by improved mix and pricing discipline, contributed meaningfully to profitability, while the Health & Wellness portfolio benefited from improving demand trends, including biotics.

The company is also advancing digital initiatives by pivoting toward regional, agile projects and accelerating its data and analytics capabilities, while maintaining investment in cybersecurity and network resilience. Hence, the company looks forward to investing in its portfolio to bolster growth and differentiation, including the plant digitization, operating leverage and higher marketing volumes in targeted markets.

ADM’s Price Performance, Valuation and Estimates

Archer Daniels shares have gained 12% in the past six months compared with the industry’s 6.9% growth.

Zacks Investment Research
Image Source: Zacks Investment Research

From a valuation standpoint, ADM trades at a forward price-to-earnings ratio of 16.86X compared with the industry’s average of 15.51X.

Zacks Investment Research
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for ADM’s 2026 and 2027 earnings per share (EPS) indicates year-over-year growth of 22.7% and 13.9%, respectively. The company’s EPS estimate for 2026 and 2027 has moved north in the past 30 days.

Zacks Investment Research
Image Source: Zacks Investment Research

Archer Daniels currently carries a Zacks Rank #3 (Hold).

Stocks to Consider in the Consumer Staples Space

Freshpet, Inc. FRPT, which is a pet food company, currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for Freshpet’s current financial-year sales indicates growth of 8.5% from the prior-year level. FRPT delivered a trailing four-quarter earnings surprise of 50%, on average.

Nomad Foods Limited NOMD, which manufactures and distributes frozen foods, currently carries a Zacks Rank of 2.

The Zacks Consensus Estimate for Nomad Foods’ current financial-year earnings is expected to rise 6.2% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 2.9%, on average.

Medifast, Inc. MED, which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED missed the average earnings surprise by a sharp margin in the trailing four quarters.

The Zacks Consensus Estimate for Medifast’s current financial-year earnings indicates growth of 30.5% from the year-ago number.

#1 Semiconductor Stock to Buy (Not NVDA)

The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.

One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.

See This Stock Now for Free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report



Archer Daniels Midland Company (ADM): Free Stock Analysis Report

Freshpet, Inc. (FRPT): Free Stock Analysis Report

MEDIFAST INC (MED): Free Stock Analysis Report

Nomad Foods Limited (NOMD): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Zacks is the leading investment research firm focusing on equities earnings estimates and stock analysis for the individual investor, including stock picks, stock screening, portfolio stock tracker and stock screeners. Copyright 2006-2026 Zacks Equity Research, Inc. editor@zacks.com (Manaing editor) webmaster@zacks.com (Webmaster)

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet